Intensity-modulated radiation therapy in newly diagnosed glioblastoma: A systematic review on clinical and technical issues

Radiotherapy and Oncology

Volumn 97, Issue 3, 2010, Pages 361-369

  Amelio, Dante ^a   Lorentini, Stefano ^a,b   Schwarz, Marco ^a   Amichetti, Maurizio ^a  

^a ATreP Provincial Agency for Proton Therapy   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Glioblastoma; Intensity modulated radiation therapy; Review; Treatment planning

Indexed keywords

ALPHA INTERFERON; CARMUSTINE; IRINOTECAN; LOMUSTINE; PENICILLAMINE; TEMOZOLOMIDE; VINCRISTINE;

CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; GLIOBLASTOMA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MONOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; SYSTEMATIC REVIEW; TREATMENT PLANNING;

BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 78650671451     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.08.018     Document Type: Review

References (41)

1. R. Stupp, M.E. Hegi, M.R. Gilbert, and A. Chakravarti Chemoradiotherapy in malignant glioma: standard of care and future directions J Clin Oncol 25 2007 4127 4136
2. J.L. Chan, S.W. Lee, and B.A. Fraass Survival and failure pattern of high-grade gliomas after three-dimensional conformal radiotherapy J Clin Oncol 20 2002 1635 1642
3. S.L. Meeks, J.M. Buatti, F.J. Bova, W.A. Friedman, W.M. Mendenhall, and R.A. Zlotecki Potential clinical efficacy of intensity-modulated conformal therapy Int J Radiat Oncol Biol Phys 40 1998 483 495
4. L. Veldeman, I. Madani, F. Hulstaert, G. De Meerleer, M. Mareel, and W. De Neve Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies Lancet Oncol 9 2008 367 375
5. NHS centre for review and dissemination. Undertaking systematic reviews of research on effectiveness. York: NHS CRD; 2001.
6. C. Thilmann, A. Zabel, K.H. Grosser, A. Hoess, M. Wannenmacher, and J. Debus Intensity-modulated radiotherapy with an integrated boost to the macroscopic tumor volume in the treatment of high-grade gliomas Int J Cancer 96 2001 341 349
7. M.F. Chan, K. Schupak, C. Burman, C.S. Chui, and C.C. Ling Comparison of intensity-modulated radiotherapy with three-dimensional conformal radiation therapy planning for glioblastoma multiforme Med Dosim 28 2003 261 265
8. M. Suzuki, K. Nakamatsu, S. Kanamori, K. Okajima, M. Okumura, and Y. Nishimura Comparison of outcomes between overlapping structure-based and non-overlapping structure-based optimization for simultaneous integrated boost IMRT for malignant gliomas Int J Clin Oncol 9 2004 491 497
9. S.M. MacDonald, S. Ahmad, and S. Kachris Intensity modulated radiation therapy versus three-dimensional conformal radiation therapy for the treatment of high grade glioma: a dosimetric comparison J Appl Clin Med Phys 8 2007 47 60
10. U. Hermanto, E.K. Frija, M.J. Lii, E.L. Chang, A. Mahajan, and S.Y. Woo Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: does IMRT increase the integral dose to normal brain? Int J Radiat Oncol Biol Phys 67 2007 1135 1144
11. M.D. Piroth, M. Pinkawa, and R. Holy Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme - a dosimetric comparison Radiat Oncol 4 2009 57
12. D. Wagner, H. Christiansen, H. Wolff, and H. Vorwerk Radiotherapy of malignant gliomas: comparison of volumetric single arc technique (RapidArc), dynamic intensity-modulated technique and 3D conformal technique Radiother Oncol 93 2009 593 596
13. L. Zach, B. Stall, and H. Ning A dosimetric comparison of four treatment planning methods for high grade glioma Radiat Oncol 4 2009 45
14. R. Shaffer, A.M. Nichol, and E. Vollans A comparison of volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for frontal and temporal high-grade gliomas Int J Radiat Oncol Biol Phys 76 2010 1177 1184
15. K. Sultanem, H. Patrocinio, and C. Lambert The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial Int J Radiat Oncol Biol Phys 58 2004 247 252
16. N.S. Floyd, Y. Woo, and B.S. Teh Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme Int J Radiat Oncol Biol Phys 58 2004 721 726
17. T. Iuchi, K. Hatano, Y. Narita, T. Kodama, T. Yamaki, and K. Osato Hypofractionated high-dose irradiation for the treatment of malignant astrocytomas using simultaneous integrated boost technique by IMRT Int J Radiat Oncol Biol Phys 64 2006 1317 1324
18. C.D. Fuller, M. Choi, and B. Forthuber Standard fractionation intensity modulated radiation therapy (IMRT) of primary and recurrent glioblastoma multiforme Radiat Oncol 2 2007 26 33
19. K. Nakamatsu, M. Suzuki, and Y. Nishimura Treatment outcomes and dose-volume histogram analysis of simultaneous integrated boost method for malignant gliomas using intensity-modulated radiotherapy Int J Clin Oncol 13 2008 48 53
20. V. Panet-Raymond, L. Souhami, and D. Roberge Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis Int J Radiat Oncol Biol Phys 73 2009 473 478
21. A.G. Morganti, M. Balducci, and M. Salvati A phase I dose-escalation study (ISIDE-BT-1) of accelerated IMRT with temozolomide in patients with glioblastoma Int J Radiat Oncol Biol Phys 77 2010 92 97
22. A. Narayana, J. Yamada, and S. Berry Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetric results Int J Radiat Oncol Biol Phys 64 2006 892 897
23. Deeks JJ, Higgins JPT, Altman DG. Chapter 9: Analysing data and undertaking meta-analysis. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions. Version 5.0.2. The Cochrane Collaboration; 2009. .
24. International commission on radiation units and measurements. Prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50) report 62. Washington, DC; 1999.
25. D. Baltas, C. Kolotas, and K. Geramani A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy Int J Radiat Oncol Biol Phys 40 1998 515 524
26. R.G. Selker, W.R. Shapiro, and P. Burger Brain Tumor Cooperative Group NIH trial 87-01 (a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiotherapy, and carmustine) Neurosurgery 51 2002 343 355
27. L. Souhami, W. Seiferheld, and D. Brachman Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: Report of Radiation Therapy Oncology Group 93-05 protocol Int J Radiat Oncol Biol Phys 60 2004 853 860
28. C. Tsien, J. Moughan, and J.M. Michalski Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98-03 Int J Radiat Oncol Biol Phys 73 2009 699 708
29. M. Hasegawa, H. Niibe, and N. Mitsuhashi Hyperfractionated and hypofractionated radiation therapy for human malignant glioma xenograft in nude mice Jpn J Cancer Res 86 1995 879 884
30. W. Budach, D. Gioioso, A. Taghian, M. Stuschke, and H.D. Suit Repopulation capacity during fractionated irradiation of squamous cell carcinomas and glioblastomas in vitro Int J Radiat Oncol Biol Phys 39 1997 743 750
31. L.R. Kleinberg, T. Slick, and C. Enger Short course radiotherapy is an appropriate option for most malignant glioma patients Int J Radiat Oncol Biol Phys 38 1997 31 36
32. M.C.C.M. Hulshof, E.C. Schimmel, and D.A. Bosch Hypofractionation in glioblastoma multiforme Radiother Oncol 54 2000 143 148
33. J.M. Galvin, G. Ezzell, and A. Eisbruch Implementing IMRT in clinical practice: a joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine Int J Radiat Oncol Biol Phys 58 2004 1616 1634
34. R. Stupp, M.E. Hegi, and W.P. Mason Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol 10 2009 459 466
35. L.A. Stewart Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials Lancet 359 2002 1011 1018
36. R. Stupp, W.P. Mason, and M.J. Van den Bent Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 10 2005 987 996
37. E.L. Chang, S. Akyurek, and T. Avalos Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma Int J Radiat Oncol Biol Phys 68 2007 144 150
38. Farace P, Giri M, Meliad G et al. Clinical target volume delineation in glioblastomas: preoperative versus postoperative-preradiotherapy MRI. Br J Radiol, in press.
39. B.J. Slotman, J.H. Kralendonk, H.A. van Alphen, W. Kamphorst, and A.B. Karim Hypofractionated radiation therapy in patients with glioblastoma multiforme: results of treatment and impact of prognostic factors Int J Radiat Oncol Biol Phys 34 1996 895 898
40. O. Lang, E. Liebermeister, J. Liesegang, and M.L. Sautter-Bihl Radiotherapy of glioblastoma multiforme. Feasibility of increased fraction size and shortened overall treatment Strahlenther Onkol 174 1998 629 632
41. M. Arslan, A.N. Karadeniz, and G. Aksu Postoperative hypofractionated radiotherapy in glioblastoma multiforme J BUON 11 2006 39 42